Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 17 de 17
1.
BMC Public Health ; 24(1): 875, 2024 Mar 21.
Article En | MEDLINE | ID: mdl-38515089

BACKGROUND: The work of church employees contains many elements causing symptoms of stress and anxiety. They can lead into psychological distress and possibly indicate the beginning of a more serious psychological state. Women seem to be more disposed to psychological stress than men. We investigated factors contributing to psychological distress among women and men in four professions of the Evangelical Lutheran Church of Finland (ELCF). METHODS: A link to an electronic survey was sent to the members of respective trade unions of four professions of the ELCF, and we got responses from pastors (n = 241), church musicians (n = 92), diaconal workers (n = 85) and youth workers (n = 56). Psychological distress was assessed using the Mental Health Inventory-5 (MHI-5; cut-off value ≤ 52 indicating severe distress). We used logistic regression to examine sociodemographic, health-related, and work-related factors that could potentially be associated with psychological distress. RESULTS: We found severe psychological distress in all profession groups. Gender differences were scarce. Loneliness was the most important factor associated with psychological distress in both men and women (OR 14.01; 95% CI 2.68-73.25 and OR 7.84; 3.44-17.88, respectively), and among pastors and church musicians (OR 8.10; 2.83-23.16 and OR 24.36; 2.78-213.72, respectively). High mental strain of work was associated with distress in women (OR 2.45; 1.01-5.97). Good work satisfaction was a protective factor for men and women (OR 0.06; 95% CI 0.01-0.40 and OR 0.61; 0.18-0.40, respectively) and for pastors and church musicians (OR 0.22; 0.08-0.73 and OR 0.06; 0.01-0.43, respectively). For women, additional protective factors were being a pastor (OR 0.26; 0.07-0.95), or youth worker (OR 0.08; 0.01-0.48), and good self-reported health (OR 0.38; 0.18-0.82). CONCLUSION: Even though we found some protective factors, the share of workers with severe distress was higher in all profession groups of the ELCF than in the general population. Loneliness was the strongest stressor among both genders and high mental strain among women. The result may reflect unconscious mental strain or subordination to the prevailing working conditions. More attention should be paid to the mental wellbeing and work conditions of church employees.


Protestantism , Psychological Distress , Adolescent , Humans , Male , Female , Finland/epidemiology , Mental Health , Anxiety , Stress, Psychological/epidemiology , Stress, Psychological/psychology
2.
Nicotine Tob Res ; 2024 Jan 19.
Article En | MEDLINE | ID: mdl-38243907

INTRODUCTION: Relatively little is known whether the association between smoking and depressive symptoms changes with age and how the trajectories of smoking and depressive symptoms are intertwined during the life course. In this population-based study, these associations were examined from young adulthood to middle age. METHODS: Participants of a Finnish cohort study (N=1955) were assessed at the ages of 22, 32, 42, and 52 using questionnaires covering daily smoking (yes/no) and the short 13-item Beck Depression Inventory. Longitudinal latent class and longitudinal latent profile analyses were used identify life course trajectories of smoking and depressive symptoms. RESULTS: The proportions of daily smokers decreased, while levels of depressive symptoms increased among both females and males from age 22 to 52 years. Smoking was associated with higher levels of depressive symptoms from age 22 to 42, while not at 52. Associations among males prevailed when adjusting for education, marital status, and alcohol use. Four life course classes of daily smoking (non-smokers, decreasing prevalence of smoking, persistent smokers, and increasing prevalence of smoking) and four trajectories of depressive symptoms (low, increasing/moderate, decreasing/moderate, and high) were identified. In males, persistent daily smokers (RRR=4.5, 95% CI: 2.2-9.2) and those in the class with increasing smoking prevalence (RRR=3.2, 95% CI: 1.1-9.1) had an increased risk of belonging to the high depressive symptoms profile. In females these associations were non-significant. CONCLUSIONS: Compared to females, the relationship between smoking and depressive symptoms seems more robust among males during adulthood. Specifically, males smoking persistently from young adulthood to middle age have an increased risk of high depressive symptoms trajectory. IMPLICATIONS: This population-based cohort with 30 years of follow-up showed that the life course trajectories of daily smoking and depressive symptoms are associated. Persistent daily smokers and those starting late had an increased risk of belonging to the profile with constantly high levels of depressive symptoms during the life course. However, these associations were statistically significant only in males. Actions should be strengthened, especially in males, to prevent smoking initiation, to help smoking cessation and identify and treat depression in smokers with significant depressive symptoms.

3.
Article En | MEDLINE | ID: mdl-36011497

Earlier research has revealed contrasting gender results in standardized mortality ratios (SMR) for cancers and cardiovascular diseases of Finnish church musicians compared with the general population. In order to better understand the SMRs, our study examined gender differences in health and work-related experiences of church musicians with special focus on experienced stress and burnout on the one hand, and work engagement and mental well-being on the other. The data were collected by a questionnaire including both standardized measures and open-ended questions. Statistical methods (mostly χ2 tests) were used for examining gender differences in the measures, and the open-ended questions were analyzed using theory-driven content analysis. The two sets of data complemented each other. Analyses of the standardized measures showed that church musicians have more burnout and distress than the general population but the results were not gendered. However, the open-ended questions revealed clearly higher distress in females than in males. Based on the contrast between the measures and the open-ended questions, we raise the question about how well females who have distressing work can recognize the stress factors and change them, especially if distress becomes a "normal state".


COVID-19 , Music , COVID-19/epidemiology , Female , Finland/epidemiology , Humans , Male , Pandemics , Protestantism
4.
Nord J Psychiatry ; : 1, 2022 Mar 22.
Article En | MEDLINE | ID: mdl-35316159

BACKGROUND: While the association between smoking and depressive symptoms has been studied quite extensively, only little is known whether the association changes and how the trajectories of smoking and depressive symptoms are intertwined during the life course. In this population-based study, we examined these associations from young adulthood to middle age. METHODS: Participants of a Finnish cohort study (N = 1955) were addressed at ages 22, 32, 42 and 52 using postal questionnaires including questions of daily smoking and depressive symptoms (the short 13-item Beck Depression Inventory). Linear and logistic regression analyses and longitudinal latent class and profile analyses were used. RESULTS: The percentages of daily smokers decreased, while levels of depressive symptoms increased among both women and men from age 22 to 52 years. Daily smoking was associated with higher levels of depressive symptoms between ages 22 and 42, while not at age 52. Associations among men prevailed also in the adjusted models. Four life course trajectories of daily smoking (non-smokers, quitters, persistent smokers, and late starters) and four depressive symptoms (low, increasing/moderate, decreasing/moderate, and high) were identified. In the adjusted models, persistent daily smokers and late starters had significantly higher risk of belonging to the high depressive symptoms profile in men, but not in women. CONCLUSIONS: Compared to women the associations between daily smoking and depressive symptoms seem more robust among men during adulthood. Especially those men smoking persistently from young adulthood to middle age have an increased risk of high depressive symptoms trajectory during the life course.

5.
BMC Public Health ; 21(1): 611, 2021 03 29.
Article En | MEDLINE | ID: mdl-33781240

BACKGROUND: Psychological distress refers to non-specific symptoms of stress, anxiety and depression, and it is more common in women. Our aim was to investigate factors contributing to psychological distress in the working population, with a special reference to gender differences. METHODS: We used questionnaire data from the nationally representative Finnish Regional Health and Well-being Study (ATH) collected in the years 2012-2016 (target population participants aged 20 +, n = 96,668, response rate 53%), restricting the current analysis to those persons who were working full-time and under 65 of age (n = 34,468). Psychological distress was assessed using the Mental Health Inventory-5 (MHI-5) (cut-off value <=52). We studied the following factors potentially associated with psychological distress: sociodemographic factors, living alone, having children under18 years of age, lifestyle-related factors, social support, helping others outside of the home and work-related factors. We used logistic regression analysis to examine association between having work-family conflict with the likelihood for psychological distress. We first performed the models separately for men and women. Then interaction by gender was tested in the combined data for those independent variables where gender differences appeared probable in the analyses conducted separately for men and women. RESULTS: Women reported more psychological distress than men (11.0% vs. 8.8%, respectively, p < 0.0001). Loneliness, job dissatisfaction and family-work conflict were associated with the largest risk of psychological distress. Having children, active participation, being able to successfully combine work and family roles, and social support were found to be protective factors. A significant interaction with gender was found in only two variables: ignoring family due to being absorbed in one's work was associated with distress in women (OR 1.30 (95% CI 1.00-1.70), and mental strain of work in men (OR 2.71 (95% CI 1.66-4.41). CONCLUSIONS: Satisfying work, family life and being able to successfully combine the two are important sources of psychological well-being for both genders in the working population.


Psychological Distress , Sex Characteristics , Adult , Child , Cross-Sectional Studies , Employment , Female , Humans , Male , Stress, Psychological/epidemiology , Young Adult
6.
Eur Child Adolesc Psychiatry ; 29(5): 595-603, 2020 May.
Article En | MEDLINE | ID: mdl-31696307

Sleep abnormalities in major depressive disorder (MDD) have been suggested to represent a vulnerability trait, which might predispose the individual to long-term psychiatric morbidity. In this study, we sought to assess whether the presence of sleep symptoms among adolescents with MDD is associated with poorer long-term outcome in young adulthood during naturalistic follow-up. Adolescent outpatients diagnosed with MDD (n = 166; age 13-19 years, 17.5% boys) were followed up during 8 years in naturalistic settings. N = 112 adolescents (16.1% boys) completed the 8-year assessment. Sleep symptoms and psychosocial functioning were assessed with structured clinical interviews, and depressive and anxiety symptoms with questionnaires. The severity of sleep symptoms at baseline was not associated with worse outcome at 8 years in terms of any of the outcome measures tested. In particular, the presence of a disturbed sleep-wake rhythm at baseline was associated with a more favourable outcome at 8 years: less depression and anxiety symptoms and higher level of psychosocial functioning. The presence of sleep symptoms in young adulthood was associated with the presence of current depression and anxiety symptoms and poorer psychosocial functioning. The presence of sleep symptoms at follow-up seems to be state-dependent: they are observed in conjunction with other psychiatric symptoms. Contrary to our hypothesis, our results suggest that sleep complaints among adolescents with MDD do not lead to poorer long-term clinical outcome in young adulthood. The link between sleep-wake rhythm disturbance and better long-term outcome needs to be confirmed and examined in detail in further studies, but here we speculate about possible explanations.


Depressive Disorder, Major/psychology , Sleep Wake Disorders/psychology , Adolescent , Adult , Female , Follow-Up Studies , Humans , Male , Treatment Outcome , Young Adult
7.
Duodecim ; 133(3): 292-300, 2017.
Article En | MEDLINE | ID: mdl-29205545

INTRODUCTION: Improving primary care services for mental health and substance abuse problems was one of the major goals of the Finnish national plan for mental health and substance abuse work. METHODS: The study data are drawn from the Regional Health and Well-being Study samples. Participants reported their health service use. RESULTS: Women and young adults used more mental health services than did men and older citizens. However, a significant proportion of those with mental health problems had not used any health services. CONCLUSIONS: More attention should be paid on reducing the stigma associated to mental health and substance abuse problems both within the health care system and the society.


Mental Disorders/therapy , Mental Health Services/statistics & numerical data , Substance-Related Disorders/therapy , Adolescent , Adult , Aged , Female , Finland/epidemiology , Humans , Male , Mental Disorders/epidemiology , Middle Aged , Primary Health Care , Social Stigma , Substance-Related Disorders/epidemiology
9.
Duodecim ; 132(7): 632-8, 2016.
Article Fi | MEDLINE | ID: mdl-27188087

Almost all schizophrenia patients suffer from various cognitive symptoms that cause difficulties in everyday living and lower the quality of life even when psychotic symptoms are in remission. Defects in social cognition constitute special problems that relate to recognizing facial expressions and understanding social situations, for example. There is no evidence that psychiatric medication improves these symptoms. On the other hand, there are several cognitive remediation programs that have been shown to be of use. New programs have also emerged to treat problems in social cognition. When neurocognitive rehabilitation is insufficient, a program that compensates for deficits in cognitive functioning is also available.


Cognition Disorders/therapy , Cognitive Behavioral Therapy/methods , Schizophrenia/therapy , Activities of Daily Living , Cognition Disorders/psychology , Humans , Quality of Life
10.
J Affect Disord ; 173: 73-80, 2015 Mar 01.
Article En | MEDLINE | ID: mdl-25462399

BACKGROUND: Up-to-date epidemiological data on depressive disorders is needed to understand changes in population health and health care utilization. This study aims to assess the prevalence of major depressive disorder (MDD) and dysthymia in the Finnish population and possible changes during the past 11 years. METHODS: In a nationally representative sample of Finns aged 30 and above (BRIF8901), depressive disorders were diagnosed with the Composite International Diagnostic Interview (M-CIDI) in 2000 and 2011. To account for nonresponse, two methods were compared: multiple imputation (MI) utilizing data from the hospital discharge register and from the interview in 2000 and statistical weighting. RESULTS: The MI-corrected 12-month prevalence of MDD was 7.4% (95% CI 5.7-9.0) and of dysthymia was 4.5% (95% CI 3.1-5.9), whereas the corresponding figures using weights were 5.4% (95% CI 4.7-6.1) for MDD and 2.0% (95% CI 1.6-2.4) for dysthymia. Women (OR 2.33, 95% CI 1.6-3.4) and unmarried people (OR 1.54, 95% CI 1.2-2.0) had a higher risk of depressive disorders. There was a significant increase in the prevalence of depressive disorders during the follow-up period from 7.3% in 2000 to 9.6% in 2011. Prevalences were two percentage points higher, on average, when using MI compared to weighting. Hospital treatments for depressive disorders and other mental disorders were strongly associated with nonparticipation. LIMITATIONS: The CIDI response rate dropped from 75% in 2000 to 57% in 2011, but this was accounted for by MI and weighting. CONCLUSIONS: Depressive disorders are a growing public health concern in Finland. Non-participation of persons with severe mental disorders may bias the prevalence estimates of mental disorders in population-based studies.


Depressive Disorder, Major/epidemiology , Dysthymic Disorder/epidemiology , Adult , Aged , Aged, 80 and over , Female , Finland/epidemiology , Follow-Up Studies , Health Surveys , Humans , Male , Middle Aged , Prevalence
11.
Schizophr Res ; 159(2-3): 309-11, 2014 Nov.
Article En | MEDLINE | ID: mdl-25217365

Hearing impairment is associated with psychotic symptoms, but has not been systematically studied in people with psychotic disorder. We used a population-based sample of 6654 persons aged 30+ to compare hearing, as measured by audiometry, in persons with schizophrenia, other non-affective psychosis and affective psychosis in the general population. The prevalence of hearing impairment did not differ in persons with psychotic disorder compared with the general population. Participants with schizophrenia and affective psychotic disorder had significantly more difficulties to hear in a noisy environment than the general population. Our results suggest that psychotic disorders are associated with minor hearing difficulties but not hearing impairment.


Hearing Loss/complications , Hearing Loss/epidemiology , Psychotic Disorders/complications , Psychotic Disorders/epidemiology , Adult , Age Distribution , Aged , Aged, 80 and over , Community Health Planning , Data Collection , Female , Finland/epidemiology , Health Surveys , Hearing Loss/diagnosis , Humans , Male , Middle Aged , Prevalence , Schizophrenia/epidemiology
12.
Psychosom Med ; 75(1): 60-7, 2013 Jan.
Article En | MEDLINE | ID: mdl-23257931

OBJECTIVE: We investigated mortality and its determinants in people with psychotic disorder. METHODS: A nationally representative two-stage cluster sample of 8028 persons aged 30 years or older from Finland was selected for a comprehensive health survey conducted from 2000 to 2001. Participants were screened for psychotic disorder, and screen-positive persons were invited for a Structured Clinical Interview for DSM-IV. The diagnostic assessment of DSM-IV psychotic disorders was based on the Structured Clinical Interview for DSM-IV, case records from mental health treatments, or both. Mortality was followed up until September 2009 and analyzed using Cox proportional hazards model. RESULTS: People with schizophrenia (hazard ratio [HR] = 3.03; 95% confidence interval [CI] = 1.93-4.77) and other nonaffective psychoses (HR = 1.84; 95% CI = 1.17-2.91) had elevated mortality risk, whereas people with affective psychoses did not (HR = 0.61; 95% CI = 0.24-1.55). Antipsychotic medication use was associated with increased mortality (HR = 2.34; 95% CI = 1.86-2.96). There was an interaction between antipsychotic medication use and the presence of a psychotic disorder: antipsychotic medication use was only associated with elevated mortality in persons who were using antipsychotics and did not have primary psychotic disorder. In persons with psychotic disorder, mortality was predicted by smoking and Type 2 diabetes at baseline survey. CONCLUSIONS: Schizophrenia and nonaffective psychoses are associated with increased mortality risk, whereas affective psychoses are not. Antipsychotic medication use increases mortality risk in older people without primary psychotic disorder, but not in individuals with schizophrenia. Smoking and Type 2 diabetes are important predictors of elevated mortality risk in persons with psychotic disorder.


Affective Disorders, Psychotic/mortality , Psychotic Disorders/mortality , Schizophrenia/mortality , Adult , Affective Disorders, Psychotic/drug therapy , Antipsychotic Agents/therapeutic use , Cohort Studies , Diabetes Mellitus, Type 2/mortality , Female , Finland/epidemiology , Follow-Up Studies , Health Surveys , Humans , Male , Middle Aged , Proportional Hazards Models , Prospective Studies , Psychotic Disorders/drug therapy , Risk Factors , Schizophrenia/drug therapy , Smoking/mortality
13.
Psychiatry Res ; 189(2): 305-11, 2011 Sep 30.
Article En | MEDLINE | ID: mdl-21798602

We investigated inflammatory markers in psychotic disorders and their association with metabolic comorbidity, antipsychotic medication, smoking, alcohol use, physical condition, and mood. From the population-based Finnish Health 2000 study, we identified all persons with schizophrenia (n=45), other nonaffective psychosis (ONAP) (n=57), affective psychosis (n=37) and chose controls matched by age, sex, and region of residence. We found that persons with schizophrenia had significantly higher sIL-2Rα, IL-1RA and C-reactive protein (CRP), persons with ONAP significantly higher IL-1RA and CRP and persons with affective psychosis almost significantly higher TNF-α compared to their matched controls. Current antipsychotic use was associated with elevated IL-1RA and CRP. After taking metabolic and lifestyle-related variables that associated with inflammatory markers into account, only antipsychotic medication remained associated with elevated IL-1RA and TNF-α which are markers related to the activation of innate immune system. CRP was influenced by both antipsychotic medication and nonaffective psychosis. sIL-2Rα, a marker of T-cell activation, was associated with depressive symptoms, schizophrenia, and affective psychosis. We conclude that in persons with psychotic disorders, activation of mononuclear phagocyte system was mostly related to metabolic comorbidity and antipsychotic medication use, whereas T-cell activation had a more direct relationship with both psychotic disorders and depressive symptoms.


Inflammation/epidemiology , Psychotic Disorders/epidemiology , Adult , Aged , Body Mass Index , C-Reactive Protein/metabolism , Community Health Planning , Comorbidity , Enzyme-Linked Immunosorbent Assay , Female , Humans , Inflammation/blood , Inflammation/diagnosis , Interleukin 1 Receptor Antagonist Protein/blood , Linear Models , Lipids/blood , Male , Middle Aged , Psychiatric Status Rating Scales , Psychotic Disorders/blood , Retrospective Studies , Statistics, Nonparametric
14.
Br J Psychiatry ; 197(5): 386-94, 2010 Nov.
Article En | MEDLINE | ID: mdl-21037216

BACKGROUND: Health utility and quality of life (QoL) are increasingly important outcome measures in healthcare and health economics. AIMS: To compare the loss of subjective QoL and utility-based health-related quality of life (HRQoL) associated with psychotic disorders. METHOD: A representative sample of 8028 Finns was screened for psychotic disorders and bipolar I disorder. Lifetime psychotic disorders were diagnosed using the Structured Clinical Interview for DSM-IV and/or case records. Health-related quality of life was measured with EQ-5D and 15D, and QoL was measured with a 10-point scale. RESULTS: Schizoaffective disorder was associated with the largest losses of QoL and HRQoL, with bipolar I disorder associated with similar or smaller losses than schizophrenia. Current depressive symptoms explained most of the losses. CONCLUSIONS: Depressive symptoms are the strongest predictors of poor QoL/HRQoL in psychotic disorders. Subjective loss of QoL associated with psychotic disorders may be smaller than objective loss of functioning suggests. The EQ-5D is problematic as an outcome measure in psychotic disorders.


Bipolar Disorder/psychology , Cost of Illness , Health Status , Psychotic Disorders/psychology , Quality of Life/psychology , Schizophrenic Psychology , Adult , Age Factors , Aged , Aged, 80 and over , Bipolar Disorder/epidemiology , Depression/epidemiology , Depression/psychology , Epidemiologic Methods , Female , Finland/epidemiology , Humans , Male , Middle Aged , Outcome Assessment, Health Care/methods , Outcome Assessment, Health Care/statistics & numerical data , Psychiatric Status Rating Scales , Psychotic Disorders/epidemiology , Review Literature as Topic , Schizophrenia/epidemiology , Self-Assessment , Socioeconomic Factors
15.
Br J Psychiatry ; 197(3): 200-6, 2010 Sep.
Article En | MEDLINE | ID: mdl-20807964

BACKGROUND: Epidemiological data on alcohol-induced psychotic disorder and delirium (alcohol-induced psychotic syndrome, AIPS) are scarce. AIMS: To investigate the epidemiology of AIPS, the risk factors for developing AIPS among people with alcohol dependence, and mortality associated with alcohol dependence with or without AIPS, in a sample drawn from the general population of Finland. METHOD: A general population sample of 8028 persons were interviewed with the Composite International Diagnostic Interview and screened for psychotic disorders using multiple sources. Best-estimate diagnoses of psychotic disorders were made using the Structured Clinical Interview for DSM-IV Axis I Disorders and case notes. Data on hospital reatments and deaths were collected from national registers. RESULTS: The lifetime prevalence was 0.5% for AIPS and was highest (1.8%) among men of working age. Younger age at onset of alcohol dependence, low socioeconomic status, father's mental health or alcohol problems and multiple hospital treatments were associated with increased risk of AIPS. Participants with a history of AIPS had considerable medical comorbidity, and 37% of them died during the 8-year follow-up. CONCLUSIONS: Alcohol-induced psychotic disorder is a severe mental disorder with poor outcome.


Alcohol-Related Disorders/epidemiology , Hospitalization/statistics & numerical data , Psychoses, Alcoholic/epidemiology , Adult , Aged , Aged, 80 and over , Alcohol Withdrawal Delirium/epidemiology , Alcohol Withdrawal Delirium/therapy , Alcohol-Related Disorders/therapy , Ambulatory Care , Diagnosis, Dual (Psychiatry) , Epidemiologic Methods , Family Health , Fathers/psychology , Female , Finland/epidemiology , Hallucinations/epidemiology , Hospitals, Psychiatric , Humans , Interview, Psychological , Male , Middle Aged , Psychoses, Alcoholic/therapy , Socioeconomic Factors
16.
Soc Psychiatry Psychiatr Epidemiol ; 44(4): 325-32, 2009 Apr.
Article En | MEDLINE | ID: mdl-18802653

BACKGROUND: There are few reports on mobility limitations in persons with psychotic disorder although restrictions in mobility may aggravate the general functional limitations of these patients. Our aim was to investigate mobility limitations among subjects with psychotic disorder in a general population-based sample. METHODS: A nationally representative sample of 6,927 persons aged 30 and older self-reported mobility limitations in an interview and was examined in performance tests. Diagnostic assessment of DSM-IV psychotic disorders combined SCID interview and case note data. Lifetime-ever diagnoses of psychotic disorder were classified into schizophrenia, other nonaffective psychotic disorders and affective psychoses. RESULTS: Self-reported mobility limitations were highly prevalent in persons with schizophrenia and other nonaffective psychosis, but not in the affective psychosis group. After adjusting for age and sex, persons with schizophrenia and other nonaffective psychoses but not affective psychoses had significantly increased odds of having both self-reported and test-based mobility limitations as well as weak muscle strength. Schizophrenia remained an independent predictor of mobility limitations even after controlling for lifestyle-related factors and chronic medical conditions. Among persons with nonaffective psychoses, higher levels of negative symptoms predicted mobility limitations. CONCLUSION: Self-reported mobility limitations are prevalent already at a young age in persons with schizophrenia and other nonaffective psychotic disorders, and among older persons with these disorders both self-reported limitations and measured performance tests show lower capacity in mobility. Difficulties in mobility are associated with negative symptoms. Mental health care professionals should pay attention to mobility limitations in persons with psychotic disorder.


Mobility Limitation , Psychotic Disorders/physiopathology , Adult , Aged , Aged, 80 and over , Data Collection , Female , Finland/epidemiology , Humans , Interviews as Topic , Male , Middle Aged , Psychotic Disorders/epidemiology , Schizophrenia/physiopathology
17.
Soc Psychiatry Psychiatr Epidemiol ; 42(11): 902-8, 2007 Nov.
Article En | MEDLINE | ID: mdl-17846698

BACKGROUND: Persons with psychotic disorder may have poorer visual acuity (VA). The aim of the study is to investigate in a general population the prevalence of impaired habitual VA and self-reported difficulties in vision among persons with different psychotic disorders. METHOD: A nationally representative sample of 6,663 persons aged 30 or older whose binocular VA for distance and for near vision was measured with current spectacles, if any. Diagnostic assessment of DSM-IV psychotic disorders used both SCID interview and case note data. Life-time ever diagnoses of psychotic disorders were classified into schizophrenia, other non-affective psychotic disorders and affective psychoses. RESULTS: After adjusting for age and sex, schizophrenia was associated with significantly increased odds of having visual impairment for distance (OR 5.04, P < 0.0001) and for near vision (OR 6.22, P < 0.0001), while other psychotic disorders were not. Self-reported problems in VA were more common in persons with schizophrenia and other non-affective psychotic disorders than in the remaining study sample. Only 43.9% of persons with schizophrenia, compared with 69.7% in the total sample (chi(2) = 13.79, d.f. 1, P = 0.0002), had had their vision examined during the 5 years before the VA measurement. CONCLUSIONS: Because persons with schizophrenia attend vision examinations substantially less frequently than others, and their vision is notably weaker, regular ocular evaluations should be included in physical health monitoring in psychotic disorders.


Antipsychotic Agents/adverse effects , Psychotic Disorders/epidemiology , Schizophrenia/epidemiology , Vision Disorders/epidemiology , Adult , Age Distribution , Aged , Aged, 80 and over , Antipsychotic Agents/therapeutic use , Cataract/epidemiology , Comorbidity , Cross-Sectional Studies , Diabetes Mellitus, Type 2/epidemiology , Female , Finland/epidemiology , Health Surveys , Humans , Interview, Psychological , Macular Degeneration/epidemiology , Male , Middle Aged , Prevalence , Psychotic Disorders/diagnosis , Psychotic Disorders/drug therapy , Schizophrenia/diagnosis , Schizophrenia/drug therapy , Sex Distribution , Vision Disorders/chemically induced , Vision Disorders/diagnosis , Vision Screening/statistics & numerical data , Visual Acuity
...